6 курс / Кардиология / Артериальные_гипертензии_в_современной_клинической_практике_Дядык

Список литературы

115.Blood pressure control, drug therapy, and kidney disease / Contreras G. [et al.] // Hypertension. — 2005. — Vol. 46, №.1. — P. 44–50.

116.Bogaert Y E. Assessing the benefits and harms of statin treatment in patients with chronic kidney disease / Y E. Bogaert, M. Chonchol // Nat. Clin. Pract. Nephrol. — 2008. — Vol. 4. — P. 470–471.

117.Campos-Outcalt D. The new cardiovascular disease prevention guidelines: what you need to know /

D.Campos-Outcalt // J. Fam. Pract. — 2014. — Vol. 63, №2. — P. 89–93.

118.Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline / J.W. Funder, R.M. Carey, C. Fardella [et al.] // J. Clin. Endocrinology & Metabolism. — 2008. — Vol. 93, №9. — Р. 3266–3281.

119.Chonchol M. Diagnosis and management of ischemic nephropathy / M. Chonchol, S. Linas // Clin. J. Amer. Soc Nephrol. — 2006. — Vol. 1. — P. 172–181.

120.Chow C. K. Prevention and control of hypertension in different countries — reply / C. K. Chow, R. Yusuf,

R.Kelishadi // J. Amer. Med. Ass. — 2014. — Vol. 311, №4. — P. 419–420.

121.Chronic kidney disease is common: What do we do next? / Coresh J. [et al.] // Nephrol. Dial. Transplant. — 2008. — Vol. 23. — P. 1122–1125.

122.Chronic kidney disease: Early identification and management of chronic kidney disease in adults in primary and secondary care. — 2008. — [Электронный ресурс]. — Режим доступа: www.nice.org. uk/accreditation.

123.Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension. / Weber M.A. [et al.] // J.Clin.Hypertens. — 2013. — [Электронный ресурс]. — Режим доступа: www.ash-us.org/ documents/ASH_ISH-Guidelines_2013.pdf

124.Cruickshank J. β-blocker therapy for patients with hypertension / J. Cruickshank // J. Amer. Med. Ass. — 2014. — Vol. 311, №8. — P. 862.

125.Cushing’s syndrome and Cushing’s disease your questions answered. — The Pituitary Society. — 2013. — 9 P.

126.Cushing’s syndrome / Newell-Price J. [et al.] // Lancet. — 2006. — Vol. 367, №9522. — P. 1605–1617.

127.deMast Q. The prevalence of artherosclerotic renal artery stenosis in risk groups: A systemic literature review / Q. de Mast, J. Beutler // J. Hypertens. — 2009. — Vol. 27. — P. 1333–1340.

128.Diagnosis and complications of Cushing’s syndrome: A consensus statement / Arnaldi G. [et al.] // J. Clin. Endocrinol. Metab. — 2003. — Vol. 88, №.12. — P. 5593–5602.

129.Diez J. Effects of aldosterone on the heart: Beyond systemic hemodynamics? / J. Diez // Hypertension. — 2008. — Vol. 52. — P. 462–464.

130.Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis / Casas J.P. [et al.] // Lancet. — 2005. — Vol. 366. —

P.2026–2033.

131.Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies / G. A. Cinotti, P. C. Zucchelli, Collaborative Study Group // Nephrol. Dial. Transplant. — 2001. — Vol. 16, №5. — P. 961–966.

132.Effect of low-dose perindopril/indapamide on albuminuria in diabetes: Preterax in Albuminuria Regression: PREMIER / Mogensen C. E. [et al.] // Hypertension. — 2003. — Vol. 41. — P. 1063–1071.

133.Effect of spironolactone on blood pressure in subjects with resistant hypertension / Chapman N. [et al.] // Hypertension. — 2007. — Vol. 49. — P. 839–845.

134.Effect of telmisartan on renal outcomes: A randomized trial / Mann J.F. [et al.] // Ann. Intern. Med. — 2009. — Vol. 151. — P. 1–2.

135.Elias M. F. Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity / M. F. Elias, K. J. Sullivan // Hypertension. — 2014. — Vol. 63, №3. — P. 16.

136.ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) / G. Mancia, R. Fagard, K. Narkiewicz [et al.] // J. Hypertens. — 2013. — Vol. 31. — P. 1281–1357.

201

Список литературы

137.Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) / Р.А. James, S. Oparil, B.L. Carter [et al.] // J. Amer. Med. Ass. — 2014. — [Электронный ресурс]. Режим доступа: http:// www.haoyisheng.com/upload/2014JNC8.pdf.

138.Expectant management of severe preeclampsia at less than 27 weeks’ gestation: Maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management / Bombrys A E. [et al.] // Amer. J. Obstet. Gynecol. — 2008. — Vol. 199. — P. 247–256.

139.Ferrari P. Forms of mineralocorticoid hypertension / P. Ferrari, O. Bonny // Vitam. Horm. — 2003. — Vol. 66. — P. 113–156.

140.Fibromuscular dysplasia / Plouin P. F. [et al.] // Orphanet. J. Rare Dis. — 2007. — Vol. 2. — P. 28.

141.Findling J W. Cushing’s Syndrome: Important issues in diagnosis and management / J W. Findling, H. Raff // J. Clin. Endocrinol. Metab. — 2006. — Vol. 91, №10. — P. 3746–3753.

142.First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation / D. M. Block-Abraham [et al.] // Obstet. Gynecol. — 2014. — Vol. 123, №3. — P. 611–617.

143.Freedman B I. Hypertension-associated kidney disease: Perhaps no more / B I. Freedman, J R. Sedor //

J.Amer. Soc. Nephrol. — 2008. — Vol. 19. — P. 2047–2051.

144.Gray R. Cardiovascular disease in the elderly / Gray R., Pack L. // Oxford, 2011. — 320 P.

145.Grantham J. J. Clinical practice: Autosomal dominant polycystic kidney disease / J J. Grantham //

N.Engl. J. Med. — 2008. — Vol. 359. — P. 1477–1485.

146.Graves J W. Diagnosis and management of chronic kidney disease / J. W. Graves // Mayo Clin. Proc. — 2008. — Vol. 83. — P. 1064–1069.

147.Griffin K A. Progression of renal disease: Renoprotective specificity of renin-angiotensin system blockade / K A. Griffin, A K. Bidani // Clin. J. Amer. Soc. Nephrol. — 2006. — Vol. 1. — P. 1054–1065.

148.Hypertension as an expression of the lack of the well-balanced life // J. Amer. Med. Ass. — 2014. — Vol. 311, №5. — P. 530.

149.Hypertension in pregnancy. — medical management. — Clinical Guidelines King Edward Memorial Hospital Perth Western Australia, 2014. — 19 P.

150.Hypertension in pregnancy / Lindheimer M D. [et al.] // J. Clin. Hypertens. — 2009. — Vol. 11, №4. —

P.214–225.

151.Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. — 2011. — [Электронный ресурс]. — Режим доступа: www.nice.org.uk/CG107.

152.Hypertension. Clinical management of primary hypertension in adults. — 2011. — [Электронный ресурс]. — Режим доступа: www.nice.org.uk/guidance/CG127.

153.IgA nephropathy in children and adults: Comparison of histologic features and clinical outcomes / Haas M. [et al.] // Nephrol. Dial. Transplant. — 2008. — Vol. 23. — P. 2537–2545.

154.Isometric exercise training for blood pressure management: a systematic review and meta-analysis /

D.J. Carlson [et al.] // Mayo Clin. Proc. — 2014. — Vol. 89, №3. — P. 327–334.

155.Kaplan’s Clinical hypertension / Ed. by N.M.Kaplan, R.G.Victor, J.T.Flynn: 10th edition. — Lippincott Williams & Wilkins, 2010. — 456 P.

156.Karavitaki N. Nonfunctioning pituitary adenomas: The consequences of a ‘watch and wait’ approach /

N.Karavitaki // Clin. Endocrinol. — 2007. — P. 1365–2265.

157.Karumanchi S A. Advances in the understanding of eclampsia / S. A. Karumanchi, M. D. Lindheimer // Curr. Hypertens. ReP. — 2008. — Vol. 10. — P. 305–312.

158.KDIGO Clinical Practice Guideline for Acute Kidney Injury / J.A Kellum, N. Lameire, P. Aspelin [et al.] // Kidney Inter. — 2012. — Vol. 2 (Suppl.). — P. 1–138.

159.KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease / J.A Kellum, N. Lameire,

P.Aspelin [et al.] // Kidney Inter. — 2012. — Vol. 2 (Suppl.). — P. 279–335.

160.KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease / G. Eknoyan, N.Lameire, Kai-Uwe Eckardt [et al.] // Kidney International. — 2013. — Vol. 3 (Suppl.). — P. 1–56.

161.KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease / A. Levin, P. E. Stevens, R.W. Bilous [et al.] // Kidney Inter. — 2012. — Vol. 3 (Suppl.). — P. 1–150.

202

Список литературы

162.KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease / J.A Kellum, N. Lameire, P. Aspelin [et al.] // Kidney Inter. — 2012. — Vol. 2 (Suppl.). — P. 337–414.

163.Lewis E J. Treating hypertension in the patient with overt diabetic nephropathy / E J. Lewis // Semin Nephrol. — 2007. — Vol. 27. — P. 182–194.

164.Liu F. Tolerability and effectiveness of (S)-amlodipine compared with racemic amlodipine in hypertension: A systemic review and meta-analysis / Liu F., Qiu M., Zhai S-D. // Current Therapeutic Research. — 2010. — Vol. 71. — P. 1–29.

165.Luther J M. Blood pressure targets in hemodialysis patients / J M. Luther, T A. Golper // Kidney Int. — 2008. — Vol. 73. — P. 667–668.

166.Magnesium sulfate decreases cerebral perfusion pressure in preeclampsia / Belfort M.[et al.] // Hypertens. Pregnancy. — 2008. — Vol. 27. — P. 315–327.

167.Major congenital malformations after first-trimester exposure to ACE inhibitors / Cooper W. O. [et al.] //

N.Engl. J. Med. — 2006. — Vol. 354. — P. 2443–2451.

168.Markun S. Blood pressure treatment is irrelevant immediately after ischemic stroke / S. Markun // Praxis. — 2014. — Vol. 103, №5. — P. 291–292.

169.Mattsson C. Primary aldosteronism: diagnostic and treatment strategies / Mattsson C., Young W.F. // Nat. Clin. Pract. Nephrol. — 2006. — Vol. 2 (4). — P. 198–208.

170.Montalescot G. 2013 Guidelines on the management of stable coronary artery disease / Montalescot G. [et al.] // Eur.Heart J. — 2013. — [Электронный ресурс]. Режим доступа: www.escardio.org/guidelines-sur- veys/escguidelines/GuidelinesDocuments/2013_Stable_Coronary_Artery_Disease_web_addenda.pdf 170a. National Institute for Health and Clinical Excellence (NICE). Clinical management of primary hypertension in adults / 2011 // [Электронный ресурс]. Режим доступа: www.nice.org.uk/nicemedia/ live/13561/56008/56008.pdf

171.Opie L., Gersh B. Drugs for the heart // Elsevier, 2013. — 592 P.

172.Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial / K. J. Schjoedt, A.S. Astrup, F.Persson [et al.] // Diabetologia. — 2009. —Vol. 52, №1. — P. 46–49.

173.Pacak K. Preoperative management of the pheochromocytoma patient / K. Pacak // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92. — P. 4069–4079.

174.Parker M. G. Resistant hypertension: Core Curriculum 2008 / M G. Parker // Amer. J. Kidney Dis. — 2008. — Vol. 52. — P. 796–802.

175.Pitt B. Spironolactone for Heart Failure with Preserved Ejection Fraction / Pitt B. [et al.] // N.Engl.J.Med. — 2014. — Vol. 370. — P. 1383–1392.

176.Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease / Silva V. S. [et al.] // Amer. J. Hypertens. — 2008. — Vol. 21. — P. 1163–1168.

177.Podymow T. Update on the use of antihypertensive drugs in pregnancy / T. Podymow, P. August // Hypertension. — 2008. — Vol. 51. — P. 960–969.

178.Prevalence and natural history of adrenal incidentalomas / Barzon L. [et al.] // Eur. J. Endocrinol. — 2003. — Vol. 149. — P. 273–285.

179.Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study / Douma S. [et al.] // Lancet. — 2008. — Vol. 371. — P. 1921–1926.

180.Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study / Remuzzi

G.[et al.] // J. Amer. Soc. Nephrol. — 2006. — Vol. 17. — P. 90–97.

181.Progression of atherosclerotic renovascular disease: A prospective population-based study / Pearce J

D.[et al.] // J. Vasc. Surg. — 2006. — Vol. 44. — P. 955–962.

182.Rahman M. M. Prevention and control of hypertension in different countries / M. M. Rahman,

S.Gilmour // J. Amer. Med. Ass. — 2014. — Vol. 311, №4. — P. 418–419.

183.Ram C. V. Fixed-dose triple-combination treatments in the management of hypertension / C. V. Ram // Manag. Care. — 2013. — Vol. 22, №12. — P. 45–55.

184.Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria / N. Chaturvedi, J. Stevenson, J.H. Fuller [et al.] // Lancet. — 1997. — Vol. 349. — P. 1787–1792.

203

Список литературы

185.Rationale and design of Faith-based Approaches in the Treatment of Hypertension (FAITH), a lifestyle intervention targeting blood pressure control among black church members / K. J. Lancaster [et al.] // Amer. Heart J. — 2014. — Vol. 167, №3. — P. 301–307.

186.Reninoma: Case report and literature review /Wong L. [et al.] // J. Hypertens. — 2008. —Vol. 26. — P. 368–373.

187.Renoprotective effects of rennin-angiotensin-system inhibitors / De Zeeuw [et al.] // Lancet. — 2006. — Vol. 367. — P. 899–900.

188.Resolution of Page kidney-related hypertension with medical therapy: A case report / Myrianthefs

P.[et al.] // Heart Lung. — 2007. — Vol. 36. — P. 377–379.

189.Rooke T.W. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines / Rooke T.W. [et al.] // Circulation. — 2011. — [Электронный ресурс]. Режим доступа:www.circ.ahajournals.org/ content/early/2011/09/29/CIR.0b013e31822e80c3.full.pdf

190.Risk factors for end-stage renal disease: 25-year follow-up / Hsu CY. [et al.] // Arch Intern. Med. — 2009. — Vol. 169. — P. 342–350.

191.Roberts J. M. Preeclampsia: New approaches but the same old problems / J. M. Roberts // Amer. J. Obstet. Gynecol. — 2008. — Vol. 199. — P. 443–444.

192.Ruilope L. M. Long-term adherence to therapy: the clue to prevent hypertension consequences / L. M. Ruilope // Eur. Heart J. — 2013. — Vol. 34. — P. 2931–2932.

193.Sarkar O. Paroxysmal hypertension / O. Sarkar, M. Baumann // MMW Fortschr Med. — 2013. — Vol. 155, №20. — P. 44, 46–47.

194.Schirpenbach C. Primary aldosteronism: Current knowledge and controversies in Conn’s syndrome /

C.Schirpenbach, M. Reincke // Nat. Clin. Pract. Endocrinol. Metab. — 2007. — Vol. 3. — P. 220–227.

195.Schlondorff D. O. Overview of factors contributing to the pathophysiology of progressive renal disease / D. O. Schlondorff // Kidney Int. — 2008. — Vol. 74. — P. 860–866.

196.Schmieder R. E. The potential role of prorenin in diabetic nephropathy / R. E. Schmieder // J. Hypertens. — 2007. — Vol. 25. — P. 1323–1326.

197.Seely E.W. Chronic hypertension in pregnancy / E.W. Seely, J. Ecker // N. Engl. J. Med. — 2011. — Vol. 365. — P. 439–446.

198.Skybchyk V. A. Erectile dysfunction in patients with hypertension: hope of sartans / V. A. Skybchyk // Артериальная гипертензия. — 2012. — №1 (21). — С. 17–22.

199.Slovut D. P. Fibromuscular dysplasia / D. P. Slovut, J. W. Olin // N. Engl. J. Med. — 2004. –Vol. 350. —

P.1862–1871.

200.Solomon C. G. Hypertension in pregnancy / C. G. Solomon, E. W. Seely // Endocrinol. Metab. Clin. North. Amer. — 2006. — Vol. 35, №1. — P. 157–171.

201.Stenting and medical therapy for atherosclerotic renal-artery stenosis / Cooper C.J., Murphy T.P. , Cutlip D.E. [et al.] // N. Engl. J. Med. — 2014. –Vol. 370., №1. — P. 13–22.

202.Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease / Cheng LT. [et al.] // Nephrol. Dial. Transplant. — 2008. — Vol. 23, №.12. — P. 3895–3900.

203.«Subclinical Cushing’s syndrome» is not subclinical: improvement after adrenalectomy in 9 patients / Mitchell I. C. [et al.] // Surgery. — 2007. — Vol. 142. — P. 900–905.

204.Task force on hypertension in pregnancy. The American College of Obstetricians and Gynecology / J.M. Roberts, P. A. August, G. Bakris [et al.] // The American College of Obstetricians and Gynecology. — 2013. — 100 р.

205.Textor S. Current approaches to renovascular hypertension / S. Textor // Med. Clin. North Amer. — 2009. — Vol. 3. — P. 717–732.

206.The Diagnosis of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline / L.K. Nieman, B. M. K. Biller, J. W. Findling [et al.] // J. Clin. Endocrinology & Metabolism. — 2008. — Vol. 93, №5. — P. 1526–1540.

207.The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trial / E. E. Vink E. E. [et al.] // Amer. Heart J. — 2014. — Vol. 167, №3. — P. 308–314.

204

Список литературы

208.The Kidney. 9th ed. / Taal M.W., Chertow G.M., Marsden P. A. [et al]. // Brenner and Rector’s, 2012. — 3064 P.

209.The management of CKD: a look into the future / Khwaja A. [et al.] // Kidney Int. — 2007. — Vol. 72. —

P.1316–1323.

210.The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer / H.Chen, R.S. Sippel, S.O’Dorisio, [et al.] // Pancreas. — 2010. — Vol. 39, №6. — Р. 775–783.

211.The pathogenesis of diabetic nephropathy / Dronavelli S. [et al.] // Nat. Clin. Pract. Endocrinol. Metab. — 2008. — Vol. 4. — P. 444–452.

212.The risk of cardiovascular events in primary care patients following an episode of severe hypertension / Ewen E. [et al.] // J Clin Hypertens. — 2009. — Vol. 11. — P. 175–182.

213.Tolerability and effectiveness of (S)-amlodipine compared with racemic amlodipine in hypertension: A systematic review and meta-analysis / F. Liu, M.Qiu, Suo-Di Zhai // Review Current Therapeutic Research. — 2010. — Vol. 71, №1. — P. 1–29.

214.Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease / Abaterusso C. [et al.] // Clin. J. Amer. Soc. Nephrol. — 2008. — Vol. 3. — P. 1185–1194.

215.Treatment of adrenocorticotropin-dependent Cushing’s syndrome: A consensus statement / Biller B.

M.[et al.] // J. Clin. Endocrinol. Metab. — 2008. — Vol. 93, №.7. — P. 2454–2462.

216.TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol / A. Salam [et al.] // Amer. Heart J. — 2014. — Vol. 167, №2. — P. 127–132

217.Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study / A. J. Lewin [et al.] // Ethn. Dis. — 2014. — Vol. 24, №1. — P. 41–47.

218.Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis / Cnossen J.S., Morris R.K., terRiet G. [et al.] // Canad. Med. Ass. J. — 2008. — Vol. 178, №6. — P. 701–711.

219.Varon J. Treatment of acute severe hypertension: current and newer agents / J. Varon // Drugs. — 2008. — Vol. 68. — P. 283–297.

220.Waeber B. Ambulatory blood pressure monitoring: essential for diagnosing and treating hypertension? /

B.Waeber, G. Wuerzner // Rev. Med. Suisse. — 2014. — Vol. 10, №412–413. — P. 57–60.

221.Washinger K. An integrated approach: hypertension management in patients with chronic kidney disease / K. Washinger // Adv. NPs. PAs. — 2014. — Vol. 5, №1. — P. 16–17.

222.Wireman Cook H. Chronic arterial hypertension / Cook H. Wireman // J. Amer. Med. Ass. — 2014. — Vol. 311, №14. — P. 1451.

223.Worksite wellness for the primary and secondary prevention of cardiovascular disease in Japan: the current delivery system and future directions / T. Okamura [et al.] // Prog. Cardiovasc. Dis. — 2014. — Vol. 56, №5. — P. 515–521.

224.Young W F. Editorial: Paraganglioma-all in the family / W. F.Young, A L. Abboud // J. Clin. Endocrinol. Metab. — 2006. — Vol. 91. — P. 790–792.

225.Young W F. Primary aldosteronism: Renaissance of a syndrome / W F. Young // Clin. Endocrinol. — 2007. — Vol. 66. — P. 607–618.

226.Young W F. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? / W F. Young, A W. Stanson // Clin. Endocrinol. — 2009. — Vol. 70. — P. 14–17.

227.Young W. F. Clinical practice: The incidentally discovered adrenal mass / W F. Young // N. Engl. J. Med. — 2007. — Vol. 356. — P. 601–610.

228.Young W. F. Pheochromocytoma / W. F. Young // ASH Clinical Hypertension Review Course Syllabus, American Society of Hypertension. — 2007. — P. 481–494.

205